Trial intelligence / Profile preview

Pregabalin versus fluoxetine for hot flashes in postmenopausal women

IRCT20250711066447N1Phase 3Recruiting

Sponsor
Vice Chancellor for Research, Birjand University of Medical Sciences
Start
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in vasomotor symptoms and night sweats comparing Pregabalin with Fluoxetine (2 arms). Primary endpoints: Hot flashes and Night sweats. Started Nov 2025; status: recruiting.

02

Drugs

pregabalinfluoxetine
03

Conditions

vasomotor symptomsnight sweats

Beyond the preview

Go deeper on IRCT20250711066447N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250711066447N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call